Studies of the release of gastrin from the human duodenum induced by gastrin-releasing peptide.
In the present study the influence of duodenal exclusion and vagotomy on basal release of gastrin from extra-antral stores has been investigated in addition to the consequences of these procedures on the gastrin response to gastrin-releasing peptide (GRP) infusion. Basal gastrin concentrations and the response to GRP were measured in seven patients after a Whipple operation, in seven patients after antrectomy combined with selective gastric vagotomy and B I reconstruction, in seven patients operated on with antrectomy, selective gastric vagotomy, and Roux-en-Y reconstruction, and finally in seven patients after antrectomy, truncal vagotomy, and Roux-en-Y reconstruction. Gastrin was measured by a highly specific radioimmunoassay. Very low concentrations were obtained after a Whipple operation, and no increase followed GRP infusion. The basal gastrin concentrations were slightly higher in antrectomized patients, irrespective of whether a selective gastric vagotomy had been added. However, in these patients a significant gastrin response followed GRP infusion. Duodenal exclusion seemed not to influence the response to GRP. On the other hand, extragastric vagotomy was followed by low gastrin concentrations in the basal state and only a marginal response to GRP administration. These results strongly suggest that GRP releases gastrin from the human duodenal mucosa and that duodenal exclusion does not alter the response of the duodenal gastrin cells to GRP stimulation. Vagal denervation of the duodenal mucosa seems to suppress the gastrin response to GRP, indicating an excitatory influence of the vagus nerve.
Dept. of Surgery, Sahlgren's Hospital, University of Gothenburg, Sweden.
M
M
Sjövall
L
L
Lundell
J F
JF
Rehfeld
L
L
Olbe
D000328:Adult; D000368:Aged; D000713:Anastomosis, Roux-en-Y / Q000009:adverse effects; D004385:Duodenostomy / Q000009:adverse effects; D004386:Duodenum / Q000378:metabolism* / Q000601:surgery; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000601:surgery; D010455:Peptides / Q000008:administration & dosage*; D011706:Pyloric Antrum / Q000601:surgery; D013270:Stomach / Q000601:surgery; D014629:Vagotomy, Proximal Gastric / Q000009:adverse effects; D015167:Vagotomy, Truncal / Q000009:adverse effects
D005755:Gastrins; D010455:Peptides; D019886:Gastrin-Releasing Peptide